Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)
- 31 July 2006
- journal article
- review article
- Published by Elsevier BV in Experimental Neurology
- Vol. 200 (1), 8-18
- https://doi.org/10.1016/j.expneurol.2006.01.021
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 48 references indexed in Scilit:
- Modulation of neurodegeneration by molecular chaperonesNature Reviews Neuroscience, 2005
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neuronsFrontiers in Neuroendocrinology, 2004
- Mutant dynactin in motor neuron diseaseNature Genetics, 2003
- Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular AtrophyPublished by Elsevier BV ,2002
- Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular AtrophyNeuron, 2002
- Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 familiesNeuromuscular Disorders, 2000
- Chaperones Hsp70 and Hsp40 Suppress Aggregate Formation and Apoptosis in Cultured Neuronal Cells Expressing Truncated Androgen Receptor Protein with Expanded Polyglutamine TractPublished by Elsevier BV ,2000
- Caspase-3 Cleaves the Expanded Androgen Receptor Protein of Spinal and Bulbar Muscular Atrophy in a Polyglutamine Repeat Length-Dependent MannerBiochemical and Biophysical Research Communications, 1998
- Severity of X‐linked recessive bulbospinal neuronopathy correlates with size of the tandem cag repeat in androgen receptor geneAnnals of Neurology, 1992